Tusk Therapeutics

Tusk Therapeutics is a private immuno-oncology company focused on discovering and developing unique therapeutic antibodies that harness the power of the immune system to treat cancer. The company has built a growing, diversified antibody pipeline targeting selected novel and validated targets that play an important role in the immune response to cancer. The company’s programs target the tumor microenvironment and exert their effects by modulating, activating, and/or depleting these immune cells.